Professional Documents
Culture Documents
Epilepsy & Antiepileptic Drugs: Dr. Siva Priya Sonali Thanushanthan Tivashkar Srinaath Sidhantasahoo
Epilepsy & Antiepileptic Drugs: Dr. Siva Priya Sonali Thanushanthan Tivashkar Srinaath Sidhantasahoo
Epilepsy & Antiepileptic Drugs: Dr. Siva Priya Sonali Thanushanthan Tivashkar Srinaath Sidhantasahoo
DRUGS
Dr. Siva Priya
Sonali
Thanushanthan
Tivashkar
Srinaath
Sidhantasahoo
INTRODUCTION
•The term EPILEPSY based on Greek
word “ epilambanein” ( “meaning to
seize” ) was first used by Hippocrates.
ATONIC SEIZURE
MYCLONIC SEIZURES
MYCLONIC SEIZURES
SIMPLE PARTIAL SEIZURES
COMPLEX PARTIAL SEIZURES
DIFFERENTIAL DIAGNOSIS
Syncope attacks
Cardiac arrythmias
Migraine
Hypoglycemia
Narcolepsy
Panic attacks
PSEUDOSEIZURES
DIAGNOSTIC TESTS
People with epilepsy will often have abnormal electrical activity seen on
an electroencephalograph (EEG).
Various blood tests and other tests looking for temporary and reversible
causes of seizures, may include:
Blood chemistry
Blood sugar
CBC (complete blood count)
CSF (cerebrospinal fluid) analysis
Kidney function tests
Liver function tests
Tests for infectious diseases
Tests for the cause and location of the problem may include:
EEG
Head CT or MRI scan
Lumbar puncture (spinal tap)
COMPLICATIONS
Difficulty learning
However, proper diet and sleep, and staying away from illegal drugs
and alcohol, may decrease the likelihood of triggering seizures in people
with epilepsy.
After Seizure
1. Remove tight clothing.
2. In unconscious patient use the Recovery Position
3. Usually patient recovers on his own in his own time.
4. If time lapsed is more than 10 minutes or if first convulsion, seek
immediate medical help / ambulance.
Do not
1. Feed (liquid or solid) by mouth.
2. Gag the patient or put anything in the mouth.
3. Restrain the patient during the attack.
PHARMACOLOGIC TREATMENT
Some medications can be taken daily in order to prevent
seizures or reduce the frequency of their occurrence.
All such drugs have side effects which are idiosyncratic and
others which are dose-dependent; it is not possible to predict
who will suffer from side effects or at what dose the side
effects will appear.
Antiepileptic
Drugs
•Sodium currents/channels
•Calcium channels
•Glutamate receptors
•GABA-A receptors/channels
•Sex hormones
•Carbonic anhydrase inhibition
Mechanism of Action
At therapeutic levels (10-20 μg/ml) à blocks the use dependent
Na+ channels à inhibits the generation of repetitive action
potentials.
At higher doses à it also reduces the influx of Ca+2
à suppresses repetitive firing of neurons & neurotransmitters
Pharmacokinetics
Adverse Effects
Gingival hyperplasia
Megaloblastic anemia
Vitamin K deficiency
Vitamin D Deficiency
Hirutism
congenital malformation
Phenytoin should not be discontinued suddenly à it may
precipitate withdrawal seizures
Carbamazepine
Mechanism of Action
It blocks the use-dependent Na+ channels à inhibits high
frequency repetitive firing of the neurons in brain
Therapeutic Uses
it is the drug of choice for partial & generalized
tonic-clonic seizures
Pharmacokinetic
It is distributed mainly in brain, liver, kidneys
It is metablosied & excreted through urine
Adverse Effects
Drowsiness, dizziness, headache, slurred speech, vertigo,
ataxia, diplopia à tolerance develops over a period of few weeks
Teratogenecity
• Allergic reactions à rashes & fever
Valproic Acid (Sodium Valproate)
Valproic acid or Sodium Valproate or Valproate semisodium à it
is the valproate ion (C3H7)2.CHCOO- àwhich is active form &
absorbed from GIT
Mechanism of Action
Block use dependent Na+ channels
Inhibit GABA transaminase
Activate glutamic acid decarboxylase
At higher concentrations à it increase the membrane K+
conductance by activating K+ channels
Therapeutic uses
It is very effective against absence seizures [Basis: Inhibit
Ca+2 influx by blocking T-type Ca+2 channels]
Pharmacokinetics
well absorbed orally
Adverse Effects
Dose related – Weight gain, increase in appetite, GIT distress,
Idiosyncratic reaction
Clinical Trial Example……..
EFFECTS OF ANTIEPILEPTIC DRUGS ON
BRAIN EXCITABILITY
This study has been completed.
First Received on February 15, 2003. Last
Updated on March 3, 2008
PURPOSE
This study will evaluate the usefulness of transcranial magnetic stimulation (TMS) in
measuring cortical excitability. The cortex is the outer part of the brain. Patients with
seizures have increased cortical excitability and are often treated with antiepileptic
drugs to reduce this excitability.
The therapeutic effects of antiepileptic drugs are usually tracked with blood tests
that measure their blood levels. However, these blood tests may not always correctly
reflect the effects of the drugs on the brain.
TMS has been used successfully to measure cortical excitability in many
neurological diseases, including epilepsy, and may be helpful in
measuring drug effects on the brain directly.
OBJECTIVES
Transcranial magnetic stimulation (TMS) is a non-invasive technique
that allows accurate measures of this parameter. The purpose of this
protocol is to test the hypothesis that TMS measures of cortical
excitability will correlate with serum blood levels of AEDs, and reflect
clinical effects on cortical function directly in healthy volunteers.